0

Nucleic Acid Amplification Market by Technique and Geography - Forecast and Analysis 2022-2026

  • Published: May 2022
  • Pages: 124
  • SKU: IRTNTR73403
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The nucleic acid amplification market share is expected to reach an estimated value of USD 1.47 billion by 2026 at an accelerating CAGR of 7.73%.

This nucleic acid amplification market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. The nucleic acid amplification market report also offers information on several market vendors, including Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Hangzhou Ltd. among others.

This report extensively covers nucleic acid amplification market segmentation by the following:

  • Technique - Target amplification, Probe amplification, and Signal amplification
  • Geography - North America, Europe, Asia, and Rest of World (ROW)

What will the Nucleic Acid Amplification Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Nucleic Acid Amplification Market Size for the Forecast Period and Other Important Statistics

 

Nucleic Acid Amplification Market: Key Drivers, Trends, and Challenges

The increasing research and development (R&D) activities at academic institutes and medical organizations is notably driving the nucleic acid amplification market growth, although factors such as lack of skilled workforce to handle may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the nucleic acid amplification market industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Nucleic Acid Amplification Market Driver

One of the key factors driving growth in the nucleic acid amplification market is the increasing research and development (R&D) activities at academic institutes and medical organizations. Academic institutions and medical organizations utilize nucleic acid amplification techniques to carry out research studies on applications of molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology. R&D activities at academic institutes and medical organizations include bioinformatics and genome sequencing, and these academic institutes and medical organizations provide DNA sequencing services to companies. Such research studies on genome sequencing and genetics, in turn, increase the adoption of nucleic acid amplification by research laboratories. Owing to the outbreak of COVID-19 in 2020, several numerous academic institutes and medical organizations across the world conducted research studies to identify potential treatments for the disease. These institutes make use of nucleic acid amplification techniques to conduct their R&D activities.

Key Nucleic Acid Amplification Market Trend

The increasing investment in the development of new biotechnological techniques is a nucleic acid amplification market trend that is expected to have a positive impact in the coming years. In recent years, end-users such as hospitals, diagnostic centers, academic institutes, and research organizations have been increasingly opting for nucleic acid amplification for disease diagnosis. Nucleic acid amplification is highly used by end-users for the detection of molecular infectious diseases. The advent of the nucleic acid amplification technique, coupled with the development of genomics, has significantly increased the use of molecular biology enzymes, kits, and reagents for the detection of pathogenic events at the genomic level. Such rising use of nucleic acid amplification for exploring disease-related genes and management of infectious diseases is expected to positively impact the growth of the global nucleic acid amplification market.

Key Nucleic Acid Amplification Market Challenge

The lack of skilled workforce to handle will be a major challenge for the nucleic acid amplification market during the forecast period. Nucleic acid amplification needs skilled professionals such as pathologists and clinicians who can perform nucleic acid amplification tests, genotyping tests, and predisposition diagnostic tests. Their responsibilities also include understanding the underlying molecular mechanisms of diseases to treat patients according to their medical condition. Skilled professionals are required to carry out a range of routine and advanced tests in laboratory-based microbiology/virology safely and competently using standard operating procedures (SOPs). The lack of adequate training and courses on nucleic acid amplification tests available for the detection and staging of a disease is one of the prime factors limiting the number of students graduating to become laboratory technicians.

This nucleic acid amplification market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global nucleic acid amplification market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the nucleic acid amplification market during the forecast period.

Who are the Major Nucleic Acid Amplification Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Abbott Laboratories
  • Becton Dickinson and Co.
  • bioMerieux SA
  • Danaher Corp.
  • Eiken Chemical Co. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Hologic Inc.
  • Illumina Inc.
  • LGC Ltd.
  • Meridian Bioscience Inc.
  • New England Biolabs Inc.
  • Novartis AG
  • OptiGene Ltd.
  • Promega Corp.
  • Quidel Corp.
  • Siemens AG
  • Tecan Group Ltd.
  • Thermo Fisher Scientific Inc.
  • Ustar Biotechnologies Hangzhou Ltd. 

 

This statistical study of the nucleic acid amplification market encompasses successful business strategies deployed by the key vendors. The nucleic acid amplification market is fragmented and the vendors are deploying growth strategies such as innovative product offerings to compete in the market.

Product Insights and News

  • Abbott Laboratories - Abbott Laboratories is a public company headquartered in US. It is a global company generating $43,075 million in revenues and has around 113,000 employees. Its revenue from the global nucleic acid amplification market contributes to its overall revenues along with its other offerings, but it is not a key revenue stream for the company. 
  • Abbott Laboratories - The company offers nucleic acid amplification platform namely Abbott RealTime SARS CoV 2 Amplification reagent kit. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The nucleic acid amplification market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Nucleic Acid Amplification Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the nucleic acid amplification market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Nucleic Acid Amplification Market?

For more insights on the market share of various regions Request for a FREE sample now!

38% of the market’s growth will originate from North America during the forecast period. US and Canada are the key markets for nucleic acid amplification in North America. Market growth in this region will be slower than the growth of the market in the European and Asian regions.

The presence of a large number of testing laboratories, research facilities, sub-contract laboratories, and pharmaceutical companies will facilitate the nucleic acid amplification market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

The nucleic acid amplification market witnessed a positive impact during the outbreak of COVID-19 in 2020. Nucleic acid amplification is utilized in diagnostics and drug discovery which led to an increase in demand for nucleic acid amplification. Industry players started focusing on developing digital PCR kit tests to detect COVID-19. Regulatory authorities were also extending support to approve these tests to combat the consequences of the COVID-19 outbreak. Furthermore, the demand for nucleic acid amplification such as RT-PCR increased significantly during the pandemic, and nucleic acid amplification continues to be in demand. The market witnessed several approvals and the launch of PCR kits for COVID-19 detection.

What are the Revenue-generating Technique Segments in the Nucleic Acid Amplification Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The nucleic acid amplification market share growth by the target amplification.segment will be significant during the forecast period. The target amplification technique is increasingly opted for molecular biology diagnoses, which is required to carry out biotechnology research. Pharmaceutical companies are also opting for the target amplification techniques to discover and develop new drugs, owing to the increasing prevalence of chronic and infectious diseases globally.  The target amplification technique is increasingly used by biotechnology and pharmaceutical companies for drug development, which, in turn, propels the global nucleic acid amplification market during the forecast period.

This report provides an accurate prediction of the contribution of all the segments to the growth of the nucleic acid amplification market size and actionable market insights on post COVID-19 impact on each segment.

 

Nucleic Acid Amplification Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 7.73%

Market growth 2022-2026

$ 1.47 billion

Market structure

Fragmented

YoY growth (%)

5.3

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 38%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., and Ustar Biotechnologies Hangzhou Ltd. 

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Nucleic Acid Amplification Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive nucleic acid amplification market growth during the next five years
  • Precise estimation of the nucleic acid amplification market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the nucleic acid amplification market industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of nucleic acid amplification market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technique
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Technique

    • 5.1 Market segments
      • Exhibit 24: Chart on Technique - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Technique - Market share 2021-2026 (%)
    • 5.2 Comparison by Technique
      • Exhibit 26: Chart on Comparison by Technique
      • Exhibit 27: Data Table on Comparison by Technique
    • 5.3 Target amplification - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Target amplification - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Target amplification - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Target amplification - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Target amplification - Year-over-year growth 2021-2026 (%)
    • 5.4 Probe amplification - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Probe amplification - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Probe amplification - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Probe amplification - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Probe amplification - Year-over-year growth 2021-2026 (%)
    • 5.5 Signal amplification - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Signal amplification - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Signal amplification - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Signal amplification - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Signal amplification - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Technique
      • Exhibit 40: Market opportunity by Technique ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 China - Market size and forecast 2021-2026
      • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.10 UK - Market size and forecast 2021-2026
      • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.11 Canada - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 85: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 86: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 87: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 88: Matrix on vendor position and classification
            • 10.3 Abbott Laboratories
              • Exhibit 89: Abbott Laboratories - Overview
              • Exhibit 90: Abbott Laboratories - Business segments
              • Exhibit 91: Abbott Laboratories - Key news
              • Exhibit 92: Abbott Laboratories - Key offerings
              • Exhibit 93: Abbott Laboratories - Segment focus
            • 10.4 Becton Dickinson and Co.
              • Exhibit 94: Becton Dickinson and Co. - Overview
              • Exhibit 95: Becton Dickinson and Co. - Business segments
              • Exhibit 96: Becton Dickinson and Co. - Key news
              • Exhibit 97: Becton Dickinson and Co. - Key offerings
              • Exhibit 98: Becton Dickinson and Co. - Segment focus
            • 10.5 bioMerieux SA
              • Exhibit 99: bioMerieux SA - Overview
              • Exhibit 100: bioMerieux SA - Business segments
              • Exhibit 101: bioMerieux SA - Key offerings
              • Exhibit 102: bioMerieux SA - Segment focus
            • 10.6 Hologic Inc.
              • Exhibit 103: Hologic Inc. - Overview
              • Exhibit 104: Hologic Inc. - Business segments
              • Exhibit 105: Hologic Inc. - Key news
              • Exhibit 106: Hologic Inc. - Key offerings
              • Exhibit 107: Hologic Inc. - Segment focus
            • 10.7 LGC Ltd.
              • Exhibit 108: LGC Ltd. - Overview
              • Exhibit 109: LGC Ltd. - Product / Service
              • Exhibit 110: LGC Ltd. - Key offerings
            • 10.8 Meridian Bioscience Inc.
              • Exhibit 111: Meridian Bioscience Inc. - Overview
              • Exhibit 112: Meridian Bioscience Inc. - Business segments
              • Exhibit 113: Meridian Bioscience Inc. - Key offerings
              • Exhibit 114: Meridian Bioscience Inc. - Segment focus
            • 10.9 New England Biolabs Inc.
              • Exhibit 115: New England Biolabs Inc. - Overview
              • Exhibit 116: New England Biolabs Inc. - Product / Service
              • Exhibit 117: New England Biolabs Inc. - Key news
              • Exhibit 118: New England Biolabs Inc. - Key offerings
            • 10.10 OptiGene Ltd.
              • Exhibit 119: OptiGene Ltd. - Overview
              • Exhibit 120: OptiGene Ltd. - Product / Service
              • Exhibit 121: OptiGene Ltd. - Key offerings
            • 10.11 Promega Corp.
              • Exhibit 122: Promega Corp. - Overview
              • Exhibit 123: Promega Corp. - Product / Service
              • Exhibit 124: Promega Corp. - Key offerings
            • 10.12 Quidel Corp.
              • Exhibit 125: Quidel Corp. - Overview
              • Exhibit 126: Quidel Corp. - Product / Service
              • Exhibit 127: Quidel Corp. - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 128: Inclusions checklist
                • Exhibit 129: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 130: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 131: Research methodology
                • Exhibit 132: Validation techniques employed for market sizing
                • Exhibit 133: Information sources
              • 11.5 List of abbreviations
                • Exhibit 134: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The nucleic acid amplification market growth will increase by $1476.18 million during 2022-2026.
              The nucleic acid amplification market is expected to grow at a CAGR of 7.73% during 2022-2026.
              Technavio has segmented the nucleic acid amplification market by geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Abbott Laboratories, Becton Dickinson and Co., bioMerieux SA, Danaher Corp., Eiken Chemical Co. Ltd., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., Illumina Inc., LGC Ltd., Meridian Bioscience Inc., New England Biolabs Inc., Novartis AG, OptiGene Ltd., Promega Corp., Quidel Corp., Siemens AG, Tecan Group Ltd., Thermo Fisher Scientific Inc., Ustar Biotechnologies Hangzhou Ltd.  are a few of the key vendors in the nucleic acid amplification market.
              North America will register the highest growth rate of 38.16% among the other regions. Therefore, the nucleic acid amplification market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the nucleic acid amplification market growth are:
              • Increasing research and development (R&D) activities at academic institutes and medical organizations

                Academic institutions and medical organizations utilize nucleic acid amplification techniques to carry out research studies on applications of molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology. R&D activities at academic institutes and medical organizations include bioinformatics and genome sequencing, and these academic institutes and medical organizations provide DNA sequencing services to companies. Such research studies on genome sequencing and genetics, in turn, increase the adoption of nucleic acid amplification by research laboratories. 

                Owing to the outbreak of COVID-19 in 2020, several numerous academic institutes and medical organizations across the world conducted research studies to identify potential treatments for the disease. These institutes make use of nucleic acid amplification techniques to conduct their R&D activities. Furthermore, in March 2020, the National Institutes of Health (NIH), the medical research agency of the US, received approximately $4.9 billion of grants worth funding to perform COVID-19 research on diagnostic tests, vaccines, and treatments. In March 2020, the NIH received $940 million worth of funding from the COVID-19 Aid, Relief, and Economic Security (CARES) Act. Such factors are expected to propel the growth of the global nucleic acid amplification market during the forecast period.


              • Increasing investment in the development of new biotechnological techniques

                In recent years, end-users such as hospitals, diagnostic centers, academic institutes, and research organizations have been increasingly opting for nucleic acid amplification for disease diagnosis. For instance, vendors offer different PCR kits in their portfolio of diagnostic assays to hospitals, community clinics, pathology laboratories, and immunology laboratories for diagnosis of diseases, pathogen detection, and viral load monitoring. 

                Nucleic acid amplification is highly used by end-users for the detection of molecular infectious diseases. The advent of the nucleic acid amplification technique, coupled with the development of genomics, has significantly increased the use of molecular biology enzymes, kits, and reagents for the detection of pathogenic events at the genomic level. Such rising use of nucleic acid amplification for exploring disease-related genes and management of infectious diseases is expected to positively impact the growth of the global nucleic acid amplification market during the forecast period.


              The nucleic acid amplification market vendors should focus on grabbing business opportunities from the segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>